BioLife Solutions Inc
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, inc… Read more
BioLife Solutions Inc (BLFS) - Total Assets
Latest total assets as of December 2025: $405.88 Million USD
Based on the latest financial reports, BioLife Solutions Inc (BLFS) holds total assets worth $405.88 Million USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BioLife Solutions Inc - Total Assets Trend (1988–2025)
This chart illustrates how BioLife Solutions Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
BioLife Solutions Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
BioLife Solutions Inc's total assets of $405.88 Million consist of 29.6% current assets and 70.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 8.1% |
| Accounts Receivable | $7.95 Million | 2.0% |
| Inventory | $30.16 Million | 7.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $4.26 Million | 1.1% |
| Goodwill | $208.59 Million | 51.4% |
Asset Composition Trend (1988–2025)
This chart illustrates how BioLife Solutions Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BioLife Solutions Inc's current assets represent 29.6% of total assets in 2025, a decrease from 100.0% in 1988.
- Cash Position: Cash and equivalents constituted 8.1% of total assets in 2025, down from 80.0% in 1988.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 52.0% of total assets, an increase from 0.0% in 1988.
- Asset Diversification: The largest asset category is goodwill at 51.4% of total assets.
BioLife Solutions Inc Competitors by Total Assets
Key competitors of BioLife Solutions Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
BioLife Solutions Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - BioLife Solutions Inc generates 0.24x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - BioLife Solutions Inc is currently not profitable relative to its asset base.
BioLife Solutions Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.23 | 4.54 | 7.11 |
| Quick Ratio | 3.92 | 3.66 | 6.40 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $97.20 Million | $ 116.03 Million | $ 100.16 Million |
BioLife Solutions Inc - Advanced Valuation Insights
This section examines the relationship between BioLife Solutions Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.71 |
| Latest Market Cap to Assets Ratio | 1.90 |
| Asset Growth Rate (YoY) | 1.6% |
| Total Assets | $405.88 Million |
| Market Capitalization | $771.13 Million USD |
Valuation Analysis
Above Book Valuation: The market values BioLife Solutions Inc's assets above their book value (1.90 x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: BioLife Solutions Inc's assets grew by 1.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for BioLife Solutions Inc (1988–2025)
The table below shows the annual total assets of BioLife Solutions Inc from 1988 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $405.88 Million | +1.60% |
| 2024-12-31 | $399.49 Million | -3.20% |
| 2023-12-31 | $412.71 Million | -8.33% |
| 2022-12-31 | $450.23 Million | -18.53% |
| 2021-12-31 | $552.60 Million | +135.32% |
| 2020-12-31 | $234.83 Million | +152.47% |
| 2019-12-31 | $93.01 Million | +104.57% |
| 2018-12-31 | $45.47 Million | +274.43% |
| 2017-12-31 | $12.14 Million | +53.19% |
| 2016-12-31 | $7.93 Million | -35.92% |
| 2015-12-31 | $12.37 Million | -23.04% |
| 2014-12-31 | $16.07 Million | +379.31% |
| 2013-12-31 | $3.35 Million | +5.79% |
| 2012-12-31 | $3.17 Million | +90.72% |
| 2011-12-31 | $1.66 Million | +26.96% |
| 2010-12-31 | $1.31 Million | -1.87% |
| 2009-12-31 | $1.33 Million | +13.95% |
| 2008-12-31 | $1.17 Million | +61.24% |
| 2007-12-31 | $726.02K | +29.55% |
| 2006-12-31 | $560.43K | +25.35% |
| 2005-12-31 | $447.11K | -46.34% |
| 2004-12-31 | $833.27K | -71.89% |
| 2003-12-31 | $2.96 Million | +844.38% |
| 2002-12-31 | $313.85K | -82.33% |
| 2001-12-31 | $1.78 Million | -55.46% |
| 2000-12-31 | $3.99 Million | +84.74% |
| 1999-12-31 | $2.16 Million | -20.84% |
| 1998-12-31 | $2.73 Million | -29.69% |
| 1997-12-31 | $3.88 Million | -35.83% |
| 1996-12-31 | $6.04 Million | -28.06% |
| 1995-12-31 | $8.40 Million | 0.00% |
| 1994-12-31 | $8.40 Million | -7.66% |
| 1993-12-31 | $9.10 Million | +8.33% |
| 1992-12-31 | $8.40 Million | -35.38% |
| 1991-12-31 | $13.00 Million | +132.14% |
| 1990-12-31 | $5.60 Million | +60.00% |
| 1989-12-31 | $3.50 Million | +600.00% |
| 1988-12-31 | $500.00K | -- |